
    
      The purpose of this observational study is to give an overview of the use of PASCONAL
      NERVENTROPFEN in a 2-4 week treatment of nervous diseases, especially sleep disorders due to
      nervousness.

      Efficacy and tolerability of the drug will be assessed. Special regard will be taken to the
      administration management, dose regimen, and to the effectiveness and safety in special
      patient groups (children 1-12 years of age), in relation to treatment conformity to the
      Summary of Product Characteristics (SmPC).
    
  